BRIC
View Older Stories View More Recent Stories
-
BRICKCRAFT Official Launches With Bob Marley Tribute Sets
-
BRICKCRAFT Official Launches With Bob Marley Tribute Sets
-
Brickell Biotech (BBI) Regains Nasdaq Compliance
-
Brickell Biotech Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
BRICS Media Should Strengthen Direct Communication to Better Serve Interests of Emerging Economies -- Media Professional
-
Bricsys Teams Up with VREX to Accelerate Virtual Reality Workflow
-
Argentina says has China's support to join BRICS group
-
Artmarket.com: the Artprice 100© index up +36% in 2021
-
Brickell Biotech to Participate at William Blair Biotech Focus Conference 2022
-
Brickell Biotech (BBI) Announces 1-For-45 Reverse Stock Split
-
Brickell Biotech Announces 1-For-45 Reverse Stock Split
-
MakerBot Donates 3D Printers in Ongoing Commitment to Make 3D Printing Accessible for STEM Education and Youth Development
-
Iran applies to join China and Russia in BRICS club
-
Brick Lane Real Estate Partners With Side To Elevate the Real Estate Experience With Modern Tech
-
Russia is rerouting trade and oil to BRICS countries - Putin
-
Matthews (MATW) Acquires OLBRICH GmbH and R+S Automotive GmbH
-
Black Resilience in Colorado (BRIC) Fund Becomes a National Model for African American Focused Philanthropy
-
DUNN-EDWARDS CORPORATION ANNOUNCES 2023 COLOR + DESIGN TRENDS
-
The Robert Randolph Foundation announces JUNETEENTH UNITYFEST 2022, a national experience uniting diverse voices in commemoration and celebration of Juneteenth and Black culture
-
Brickit, the Killer App for LEGO Enthusiasts, Just Got Smarter
-
BRICS-led New Development bank to set up regional office in India
-
Brickell Biotech Doses First Subject in Phase 1 Study of DYRK1A Inhibitor BBI-02
-
Brickell Biotech Reports First Quarter 2022 Financial Results and Provides Corporate Update
-
Tantalus Systems Holding Inc. Reports Financial Results for Q1, 2022
-
Brickell Biotech to Report First Quarter 2022 Financial Results and Provide a Corporate Update on May 12, 2022
-
Brickell Biotech (BBI) Sells Sofpironium Bromide to Botanix Pharmaceuticals
-
Brickell Biotech Announces Adjournment of Annual Meeting of Stockholders
-
Brickell Biotech Announces Sale of Sofpironium Bromide to Botanix Pharmaceuticals
-
Bricz, A Leading Supply Chain Solutions Provider, Announces the Addition of Two Vice Presidents
-
Qontigo launches STOXX USA ETF Industry Index and licenses it to Kiwoom
-
BrickBio Unveils Powerful Engineered RNA Therapeutic Modification Platform at AACR 2022
-
BrickBio Debuts Powerful Advantage of Novel ADCs, Protein Origami, and Synthetic Virology at 2022 AACR
-
Form D Las Olas Capital - BRIC
-
Mayville Engineering Company Inc. (MEC) Announces Retirement Plan of CEO Robert D. Kamphuis
-
Brickless Developers Group Launches Construction on Virtual World of Metaverse and Reality
-
Brickell City Centre Continues Momentum with Nine New Tenants
-
Brick & Mortar: Better Than Ever.
-
Four weeks of war scar Russia's economy
-
Tantalus Systems Holding Inc. Reports Financial Results for Fourth Quarter and Fiscal 2021
-
Brickell Biotech Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
-
Brickell Biotech Selected for a Late-Breaking Oral Presentation of US Phase 3 Pivotal Cardigan I and Cardigan II Study Results for Sofpironium Bromide Gel, 15% at the 2022 AAD Annual Meeting
-
The Brooklyn Tower Launches Sales for the Borough's Highest Condominium Residences
-
Brickell Biotech to Report Fourth Quarter and Full Year 2021 Financial Results and Provide a Corporate Update on March 15, 2022
-
Brickworks Celebrates Global Flagship Design Studio in New York City
-
BrickSeek Debuts Its Mobile Shopping App for Deals On-Demand
-
Tantalus Systems Announces 2021 Business Highlights with Strong Momentum Heading into 2022
-
Brickworks North America Corporation Expands Direct Distribution Network with the Bolt-On Acquisition of Long-Established Washington D.C. Masonry Supplier, Capital Brick
-
Brickell Biotech (BBI) Acquires Exclusive Global Rights to Portfolio of Novel STING Inhibitors Targeting Autoimmune and Inflammatory Diseases from Carna Biosciences
-
Brickell Biotech Acquires Exclusive Global Rights to Portfolio of Novel STING Inhibitors Targeting Autoimmune and Inflammatory Diseases from Carna Biosciences
-
Bricz, A Leading Supply Chain Solutions Provider, Announces Rebrand and Expands Solution Offerings

